10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 341 filers reported holding 10X GENOMICS INC in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $446,000 | +33.1% | 5,863 | +160.7% | 0.02% | +25.0% |
| Q4 2021 | $335,000 | +71.8% | 2,249 | +68.1% | 0.01% | +100.0% |
| Q3 2021 | $195,000 | -89.0% | 1,338 | -85.3% | 0.01% | -89.7% |
| Q2 2021 | $1,780,000 | +101.8% | 9,088 | +45.8% | 0.06% | +45.0% |
| Q4 2020 | $882,000 | +3050.0% | 6,232 | +1859.7% | 0.04% | +1233.3% |
| Q2 2020 | $28,000 | -90.8% | 318 | -94.7% | 0.00% | -96.6% |
| Q3 2019 | $304,000 | – | 6,029 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |